SOPHIA GENETICS SA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.6 USD | -7.44% |
|
-8.73% | -2.34% |
| 07/05 | Transcript : SOPHiA GENETICS SA, Q1 2024 Earnings Call, May 07, 2024 | |
| 07/05 | SOPHiA GENETICS SA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 900.4 | 132.3 | 306.8 | 324.5 | - | - |
| Enterprise Value (EV) 1 | 635.1 | -29.03 | 183.5 | 265.6 | 306.7 | 320.5 |
| P/E ratio | -10.6 x | -1.51 x | -3.86 x | -5.18 x | -6.32 x | -7.77 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 22.3 x | 2.78 x | 4.92 x | 4.11 x | 3.18 x | 2.45 x |
| EV / Revenue | 15.7 x | -0.61 x | 2.94 x | 3.36 x | 3.01 x | 2.42 x |
| EV / EBITDA | -9.36 x | 0.35 x | -2.76 x | -4.73 x | -7.14 x | -10.6 x |
| EV / FCF | -1,04,75,951 x | 3,91,300 x | - | - | - | - |
| FCF Yield | -0% | 0% | - | - | - | - |
| Price to Book | 3.27 x | 0.66 x | - | 3.09 x | 4.52 x | 5.12 x |
| Nbr of stocks (in thousands) | 63,858 | 64,211 | 65,132 | 65,301 | - | - |
| Reference price 2 | 14.10 | 2.060 | 4.710 | 4.970 | 4.970 | 4.970 |
| Announcement Date | 15/03/22 | 07/03/23 | 05/03/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 40.45 | 47.56 | 62.37 | 79.02 | 102 | 132.3 |
| EBITDA 1 | - | -67.88 | -82.25 | -66.49 | -56.21 | -42.96 | -30.19 |
| EBIT 1 | - | -71.49 | -87.82 | -74.83 | -59.97 | -47.56 | -35.69 |
| Operating Margin | - | -176.73% | -184.66% | -119.97% | -75.89% | -46.62% | -26.98% |
| Earnings before Tax (EBT) 1 | - | -73.51 | -87.58 | -78.5 | -65.1 | -47.94 | -42.8 |
| Net income 1 | -39.34 | -73.68 | -87.45 | -78.98 | -63.03 | -51.86 | -41.94 |
| Net margin | - | -182.14% | -183.87% | -126.63% | -79.76% | -50.83% | -31.7% |
| EPS 2 | -0.9300 | -1.330 | -1.360 | -1.220 | -0.9600 | -0.7867 | -0.6400 |
| Free Cash Flow | - | -60.62 | -74.19 | - | - | - | - |
| FCF margin | - | -149.87% | -155.99% | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 24/05/21 | 15/03/22 | 07/03/23 | 05/03/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 10.94 | 10.86 | 11.67 | 11.65 | 13.38 | 13.97 | 15.05 | 16.3 | 17.05 | 15.78 | 18.08 | 21.5 | 23.23 | 21.34 | 24.01 |
| EBITDA 1 | -19.78 | -23.83 | -22.69 | -22.19 | -13.53 | -17.4 | -17.78 | -14.34 | -16.96 | - | -18.7 | -12.8 | -13.7 | -10.9 | -12.3 |
| EBIT 1 | -21.01 | -25.02 | -24.08 | -23.64 | -15.08 | -19.29 | -20.05 | -16.54 | -18.95 | -18.76 | -15.97 | -13.06 | -12.55 | -15.34 | -13.54 |
| Operating Margin | -192.09% | -230.37% | -206.39% | -202.94% | -112.69% | -138.1% | -133.17% | -101.48% | -111.13% | -118.87% | -88.29% | -60.75% | -54.04% | -71.87% | -56.4% |
| Earnings before Tax (EBT) 1 | -21.9 | -25.25 | - | -23.42 | -14.23 | -19.59 | -21.32 | -13.52 | -24.05 | -13.39 | -20.9 | -14.9 | -15.9 | -15.28 | -13.48 |
| Net income 1 | -21.37 | -25.49 | - | -23.31 | -13.97 | -19.7 | -21.4 | -13.82 | -24.06 | -13.7 | -21.2 | -15.2 | -16.2 | -15.28 | -13.48 |
| Net margin | -195.43% | -234.67% | - | -200.12% | -104.39% | -141.06% | -142.13% | -84.79% | -141.13% | -86.85% | -117.23% | -70.7% | -69.74% | -71.59% | -56.15% |
| EPS 2 | -0.3300 | -0.4000 | -0.3900 | -0.3600 | -0.2200 | -0.3100 | -0.3300 | -0.2100 | -0.3700 | -0.2100 | -0.3300 | -0.2300 | -0.2500 | -0.2333 | -0.2100 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 15/03/22 | 10/05/22 | 09/08/22 | 08/11/22 | 07/03/23 | 09/05/23 | 08/08/23 | 07/11/23 | 05/03/24 | 07/05/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - |
| Net Cash position 1 | - | 265 | 161 | 123 | 59 | 17.8 | 4.02 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | - | -60.6 | -74.2 | - | - | - | - |
| ROE (net income / shareholders' equity) | - | -39.2% | -36.8% | -44.9% | -52% | -66.8% | -59.7% |
| ROA (Net income/ Total Assets) | - | -32.6% | -31% | - | - | - | - |
| Assets 1 | - | 226.1 | 282 | - | - | - | - |
| Book Value Per Share 2 | - | 4.310 | 3.120 | - | 1.610 | 1.100 | 0.9700 |
| Cash Flow per Share | - | - | -1.090 | - | - | - | - |
| Capex 1 | - | 2.68 | 4.1 | 1.49 | 2 | 2.2 | 2.8 |
| Capex / Sales | - | 6.63% | 8.61% | 2.4% | 2.53% | 2.16% | 2.12% |
| Announcement Date | 24/05/21 | 15/03/22 | 07/03/23 | 05/03/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
4.97
USD
Average target price
8.667
USD
Spread / Average Target
+74.38%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -2.34% | 325M | |
| +9.17% | 3,042B | |
| +6.91% | 83.84B | |
| +3.74% | 77.3B | |
| -13.64% | 53.92B | |
| -24.95% | 47.93B | |
| +25.57% | 47.66B | |
| +19.54% | 43.81B | |
| +64.81% | 37.42B | |
| -14.63% | 25.93B |
- Stock Market
- Equities
- SOPH Stock
- Financials SOPHiA GENETICS SA